Senomyx (SNMX)
Senomyx Expenses TTM: 40.14M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNMX Expenses TTM Rankings
| Overall | 12th percentile | 3803 of 4329 |
| Sector | 9th percentile | 407 of 452 in Basic Materials |
| Industry | 11th percentile | 48 of 54 in Specialty Chemicals |
SNMX Expenses TTM Range, Past 5 Years
| Minimum | 36.11M | Jun 2007 |
| Maximum | 44.10M | Dec 2008 |
| Average | 40.84M |
About Expenses (TTM)
YCharts calculates Expense (TTM) as the sum of the last four quarters of:
Total Revenues - Net Income
Learn More
You may also be interested in these SNMX related companies
SNMX News
Senomyx's CEO Presents at Citi 2012 Global Consumer Conference - Conference Call Transcript
May 24, 11:02AM Seeking Alpha
May 24, 11:02AM Seeking Alpha
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2012 GLOBAL CONSUMER CONFERENCE
May 17, 8:30AM Business Wire
May 17, 8:30AM Business Wire
Senomyx's CEO Presents at Deutsche Bank 37th Annual Healthcare Conference (Transcript)
May 09, 8:56PM Seeking Alpha
May 09, 8:56PM Seeking Alpha
Listen to $SNMX Senomyx, Inc. at Deutsche Bank Health Care Conference - live at 04:10 PM, ondemand after - http://stks.co/3jEs
about 24 days ago by earningscast
about 24 days ago by earningscast
Listen to $SNMX Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3eNj
about 30 days ago by earningscast
about 30 days ago by earningscast
Senomyx Announces Corporate Update and First Quarter 2012 Financial Results
May 03, 8:30AM Marketwire
May 03, 8:30AM Marketwire
Senomyx to Webcast Corporate Presentation at the Deutsche Bank 37th Annual Health Care Conference
May 01, 8:30AM Marketwire
May 01, 8:30AM Marketwire
Senomyx, Inc. First Quarter Earnings Conference Call Scheduled for May 3, 2012
Apr 26, 8:30AM Business Wire
Apr 26, 8:30AM Business Wire
Senomyx to Webcast Corporate Presentation at the 11th Annual Needham Healthcare Conference
Mar 27, 8:30AM Marketwire
Mar 27, 8:30AM Marketwire
Senomyx, Inc. [SNMX] CEO & Chairman to Ring The NASDAQ Stock Market Opening Bell
Mar 07, 10:33AM GlobeNewswire
Mar 07, 10:33AM GlobeNewswire
Senomyx to Webcast Corporate Presentation at the ROTH 24th Annual OC Growth Stock Conference
Mar 07, 8:30AM Marketwire
Mar 07, 8:30AM Marketwire
Listen to $SNMX Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2dGb
about 93 days ago by earningscast
about 93 days ago by earningscast
Senomyx Announces Corporate Update and Fourth Quarter and Full Year 2011 Financial Results
Mar 01, 8:30AM Marketwire
Mar 01, 8:30AM Marketwire
Senomyx to Webcast Corporate Presentation at the 14th Annual Needham Growth Conference
Jan 04, 8:30AM Marketwire
Jan 04, 8:30AM Marketwire
SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2011 FINANCIAL RESULTS
Oct 27, 8:30AM Business Wire
Oct 27, 8:30AM Business Wire
SENOMYX, INC. THIRD QUARTER EARNINGS CONFERENCE CALL SCHEDULED FOR OCTOBER 27, 2011
Oct 21, 8:30AM Business Wire
Oct 21, 8:30AM Business Wire
$SNMX "competitor" $RPBC on verge of insolvency. Have stevia based sweet enhancer (Reb-C vs Reb-A) licensed to IFF: http://stks.co/4ti
about 273 days ago by BioDueDiligence
about 273 days ago by BioDueDiligence
Posted last night: $INFI 2q2011 CC notes: http://stks.co/4Xx Last two 2q11 posts for $SNMX and $AIS coming today!
about 274 days ago by BioDueDiligence
about 274 days ago by BioDueDiligence
Notes from $SNMX 2q2011 call: http://goo.gl/8hUJ5 Sucralose/Spelnda enhancer is on shelves. Selected new beverage sucrose enhancer w/ $PEP
about 279 days ago by BioDueDiligence
about 279 days ago by BioDueDiligence
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE MIDWEST IDEAS INVESTOR CONFERENCE
Aug 24, 8:30AM Business Wire
Aug 24, 8:30AM Business Wire
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2011 FINANCIAL RESULTS
Aug 05, 8:30AM Business Wire
Aug 05, 8:30AM Business Wire
SENOMYX, INC. SECOND QUARTER EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 5, 2011
Aug 01, 8:30AM Business Wire
Aug 01, 8:30AM Business Wire
$SNMX $5.93 BERGER DAVID B (V.P. General Counsel & Sec.) S 3,082 @ $6.12 amnt $18,853 proc'd $586 7/7/2011 w/trading plan 11/23/2010
about 326 days ago by canarionyc
about 326 days ago by canarionyc
Sorry to post in retrospect: Raised just a bit of cash by selling $SNMX @ 5.78 Friday and $MNTA @ 20.55 today (first sale ever of this one)
about 332 days ago by BioDueDiligence
about 332 days ago by BioDueDiligence
@newyorker piece re future vision @ $PEP. Interesting: they have internal $SNMX like efforts but still signed big deal http://stk.ly/jVsi1z
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
Note that if new $PEP product contains a $SNMX sucrose or fructose enhancer, they have been coy (misleading) about status of those molecules
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
$PEP market testing 60% reduced sugar Pepsi NEXT. May be part of reason for recent $SNMX decline http://stk.ly/jreF5A
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
@mrland_news Can you share any details on what you're hearing on $SNMX or source?
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
Once again didn't quite pull the trigger on $MYRX $SNTA $SNMX $INFI being very greedy right now on these pullbacks
about 358 days ago by BioDueDiligence
about 358 days ago by BioDueDiligence
kicking myself for passing on selling some $SNMX at 6.40 the other day. But really really worth a look here at EV <$150m
about 359 days ago by BioDueDiligence
about 359 days ago by BioDueDiligence
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNMX | 2.07 | -0.26 | -11.16% | 92.66M |
| SNI | 53.43 | -1.34 | -2.45% | 6.692B |
| SNHY | 22.38 | -0.95 | -4.07% | 601.21M |
| SNH | 20.20 | -0.45 | -2.18% | 3.359B |
| SNFCA | 2.06 | -0.26 | -11.21% | 45.87M |
| SNE | 12.65 | -0.59 | -4.46% | 13.29B |
| SNDK | 31.22 | -1.48 | -4.53% | 7.926B |
| SNDA | 41.28 | +0.00 | +0.00% | |
| SNCR | 17.34 | -0.57 | -3.18% | 689.89M |
| SLW | 26.63 | +1.15 | +4.51% | 9.008B |